In vitro assays to quantify the biological activity of cytokines
Article Sidebar
Main Article Content
Abstract
Cytokines are low molecular weight molecules that play a fundamental role in the inflammatory and immune response and in numerous biological and cellular processes. They are the active ingredient in many drugs, produced to treat different diseases, many of these related to the immune system. These drugs, before being marketed, must meet a series of requirements, among which is the quantification of biological activity. The biological activity of cytokines is measured through in vivo and in vitro biological tests, the latter being the most widely used due to their greater speed and versatility. In vitro tests are carried out in places with all the necessary equipment and personnel with sufficient experience to carry them out. There are many factors that can influence the quality of these analytical methods, which must be kept under strict control for approval. For these reasons, the objective of this review is to gather the theoretical bases for conducting in vitro assays to quantify the biological activity of cytokines, as well as the factors that influence their quality.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores conservan los derechos de autor y ceden a la revista el derecho de la primera publicación y pueda editarlo, reproducirlo, distribuirlo, exhibirlo y comunicarlo en el país y en el extranjero mediante medios impresos y electrónicos. Asimismo, asumen el compromiso sobre cualquier litigio o reclamación relacionada con derechos de propiedad intelectual, exonerando de responsabilidad a la Editorial Tecnológica de Costa Rica. Además, se establece que los autores pueden realizar otros acuerdos contractuales independientes y adicionales para la distribución no exclusiva de la versión del artículo publicado en esta revista (p. ej., incluirlo en un repositorio institucional o publicarlo en un libro) siempre que indiquen claramente que el trabajo se publicó por primera vez en esta revista.
References
S. P. Commins, B. Larry y J. W. Steinke, “Immunologic messenger molecules: Cytokines, interferons and chemokines,” Allergy Clin Immunol J. 125 (2), 53-72, 2009.
G. E. Feria, C. A. Leyva, W. Concepción, A. G. Castro y I. S. Larrea, Meza, “Papel de las citoquinas en la fisiopatología de la artritis reumatoide,” Correo Científico Médico, 24(1), 2020. http://www.revcocmed.sld.cu/index.php/cocmed/article/view/3447/1778
G. Scapigliati, F. Buonocore y M. Mazzini, “Biological Activity of Cytokines: An Evolutionary Perspective”, Current pharmaceutical design, 12, 3071-81, 2006.
United States Pharmacopeia, Design and analysis of biological Assays (111), pp 108-120; (1010) Analytical Data-Interpretation and treatment, pp. 378-388, vol.1. (2014)
A. Mire-Sluis, y T. Gerrard, “Biological Assays: Their role in the development and Quality control of Recombinant Biological Medicinal Products”, Biologicals, 24(3-4), 351-362, 1996.
R. S. Schrock, “Cell-Based Potency Assays: Expectations and Realities”, BioProcessing J., 11(3), 4-12, 2012.
P.Y. Kunz, C. Kienle, M. Carere, N. Homazava y R. Kase, “In vitro bioassays to screen for endocrine active pharmaceuticals in surface and waste waters”. Pharm Biomed. Anal. J., 106, 107-115, 2015.
L. Di, “Effects of Properties on Biological Assays”, in: Drug-Like Properties: Concepts, structure Design, and Methods, pp 487-496, 2016.
C. Kienle, R. Kase y I. Werner, “Evaluation of bioassays and wastewater quality: In vitro and in vivo bioassays for the performance review in the Project” “Strategy MicroPoll”, Swiss Centre for Applied Ecotoxicology, Eawag-EPFL, Duebendorf, 2011.
C. Woo, K. M. Park, S. Jun y P. S. Chang, “A reliable and reproducible method for the lipase assay in an AOT/isooctane reverses micellar system: Modification of the cooper-soap colorimetric method”, Food Chemistry, 182, 236-241, 2015.
A. Mire-Sluis y L. Page, “Quantitative cell line based bioassays for human cytokines”. J. Inmonol. Methods, 187, 191-199, 1995.
A. Kumar y R. Sheela, “Longer period of oral administration of aspartame on cytokine response in Wistar albino rats”, Endocrinol Nutr., 62(3), 114-122, 2015.
A. Mire-Sluis y R. Thorpe, “Quantitative biological assays using cytokine responsive cell lines”, J. Inmunol. Methods, 123, 150-175, 1996.
C. M. Barros, R. K. Sakata, A. M. Issy, L. R. Gerola y R. Salomao, “Cytokines and Pain”, Rev Bras Anestesiol, 61(2), 255-265, 2011.
Z. Díaz, M. Rodríguez, J. P. Yáñez, C. Álvarez, C. Rojas, A. Benítez, P. Ciuchi, G. monasterio y R. Vernal, “Variabilidad de la síntesis de citoquinas por células dendríticas humanas estimuladas con los distintos serotipos de Aggregatibacter actinomycetecomitans”, Rev. Clin. Peridoncia Implatol. Rehabil. Oral, 6(2), 57-56, 2013.
R. Velázquez, G. Gutiérrez, M. Urbán, N. Velázquez, T. I. Fortoul, A. Reyes y A. Consuelo, “Perfil de citosinas proinflamatorias y antiinflamatorias en pacientes pediátricos con síndrome de intestino irritable”. Rev. de Gastroenterología de México, 80(1), 6-12, 2015.
G. T. López, M. L. P. Ramírez y M. S. Torres, “Participantes de la respuesta inmunológica ante la infección por SARS-CoV-2”, Alergia, asma e inmunología, 29(1), 5-15, 2020.
U. Solis y J. P. Martinez, “Opciones terapéuticas al síndrome de liberación de citocinas en pacientes con la COVID-19”. Revista Cubana de Medicina Militar, 49(3), e0200783.
M. M. Katsicas, “Tormenta de citoquinas y tormenta de información asociadas a COVID-19: consideraciones sobre el síndrome inflamatorio multisistémico en niños”, Arch Argent Pediatr, 119(1), 4-5, 2021.
L. M. Filgueira, J. B. Cervantes, O. A. Lovelle, C. Herrera, C. Figueredo, J. A. Caballero, et al., “An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases”, Immunotherapy, 13(4), 289-95, 2021.
C. A. Dinarello, “Historical insights into cytokines”. Eur J. Immunol. 37: 34-45, 2007.
F. G. Khallaf, E. O. Kehinde y A. Mostafa “Growth factors and cytokines in patients with long bone fractures and associated spinal cord injury”, J. of Orthopaedics, 13(2), 69-75, 2016.
R. A. Brashaw, R. Fujii, H. Hondermarck, S. Raffioni, Y. Wu y M. A. Yarski, “Polypeptide growth factors: Structure, function and mechanism of action”, Pure & Appl. Chem., 66 (1), 9-14, 1994.
L. A. Díaz, Concheiro, C. Álvarez y C. A. García, “Growth factors delivery from hybrid PCL-starch scaffolds processed using supercritical fluid technology”, Carbohydrate Polymers, 142, 282-292, 2016.
C. M. G. Silva, S. V. Castro, L. R. Faustino, C. Q. Rodríguez, I. R. Brito, R. Rossetto, M. V. A. Saraiva, C. C. Campello, C. H. Lobo, C. E. A. Souza, A. A. A. Moura, M. A. M. Donato, C. A. Peixoto y J. R. Figueiredo, “The effects of epidermal qrowth factor (EGF) on the in vitro development of isolated goat secondary follicles and the relative mRNA expression of EGF, EGF-R, FSH-R and P450 aromatase in cultured follicles”, Research in Veterinary Science, 94 (3), 453-461, 2013.
H. Gerónimo, “Establecimiento y Validación de Ensayos de Actividad Biológica para factores de crecimiento y citocinas, aplicados a la producción de Heberprot-P, IL-2 e IL-15”, Tesis de maestría, Centro de Ingeniería Genética y Biotecnología, 2009.
D. Li, R. Zang, S. T. Yang, J. Wang y X. Wang, “Cell-based high-throughput proliferation and cytotoxicity assays for screening traditional Chinese herbal medicines”, Process Biochemestry, 48(3), 517-524. 2013.
A. Jain, R. Jain y S. Jain, “Purification and Bioassay of Interleukin-1 and Interleukin-2 (IL-1 and IL-2)”, in: Basic Techniques in Biochemistry, Microbiology and Molecular Biology, Springer Protocols Handbooks. Humana, New York, NY, 2020. https://doi.org/10.1007/978-1-4939-9861-6_26.
M. Walz, C. Höflich, C. Walz, D. Ohde, J. Brenmoehl, M. Sawitzky, A. Vernunft, U. K. Zettl, S. Holtze, T. B. Hildebrandt, et al., “Development of a Sensitive Bioassay for the Analysis of IGF‐Related Activation of AKT/mTOR Signaling in Biological Matrices”, Cells, 10(482), 2021. https://doi.org/10.3390/cells10030482.
F. Pujol, N. Vigués, A. Guerrero, S. Jiménez, D. Gómez, M. Fernández, J. Bori, B. Valles, M. C. Riva, X. Muñoz y J. Mas, “Paper-based chromatic toxicity bioassay by analysis of bacterial ferricyanide reduction”, Analytica Chimica Acta, 910, 60-67, 2016.
C. Darne, C. Coulais, F. Terzetti, C. Fontana, S. Binet, L. Gaté y Y. Guichard, “In vitro comet and micronucleus assays do not predict morphological transforming effects of silica particles in Syrian Hamster Embryo cells”. Mutation Research/Genetic Toxycology and Enviromental Mutagenesis, 796, 23-33, 2016.
F. A. Groothuis, M. B. Heringa, B. Nicol, J. L. M. Hermens, B. J. Blaauboer y N. I. Kramer “Dose metric consideration in in vitro assays to improve quantitative in vitro-in vivo dose extraoilations”, Toxicology, 332, 30-40, 2015.
S. Wang, J. M. M. J. G. Aarts, N. M. Evers, A. A. C. M. Peijnenburg, I. M. C. M. Rietjens y T. F.H. Bovee, “Proliferation assays for estrogenecy testing with high predictive value for the in vivo uterotrophic effect”, J. Steroid Biochemestry and Molecular Biology, 128 (3-5), 98-106, 2012.
G. Eisenbrand, B. Pool-Zobel, V. Baker, M. Balls, B. J. Blaauboer, A. Boobis, A. Carere, S. Kevekordes, J. C. Lhuguenot, R. Pieters, J. Kleiner, “Methods of in vitro toxicology”, Food and Chemical Toxycology, 40, 193-236, 2002.
S. Rubinstein, P. C. Familletti y S. Pestka, “Convenient assay for interferons”, J. Virol., 37, 755-758, 1981.
J. H. Fentem, “The use of human tissues in in vitro toxicology, Summary of general discussions”, Human Experimental Toxicology, 13(2), 445-449, 1994.
M. Repetto, “Toxicología Fundamental. Métodos alternativos, Toxicidad in vitro”, Sevilla, España: Ediciones Díaz de Santos, Enpses-Mercie Group, Tercera edición, pp.303-305, 2002.
P. Liu, K. Zhang, R. Zhang, H. Yin, Y. Zhou y S. Ai, “A colorimetric assay of DNA methyltransferase activity based on the keypad lock of duplex DNA modified meso-SiO2@Fe3O4”, Analytica Chimica Acta, 920, 80-85, 2016.
L. Ramírez y L. Lozano, “Principios físicoquímicos de los colorantes utilizados en microbiología Principios físicoquímicos de los colorantes”, Nova. 18, 2020. https://doi.org/10.22490/24629448.3701.
S. A. Aaronson y G. J. Todaro, “Development of 3T3-like lines from BALB/c mouse embryo cultures. Transformation susceptibility to SV-40”, J. Cell Physiol., 72, 141-148, 1968.
T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay”, J. Immunol. Methods, 65, 55-63, 1983.
F. Denizot y R. Lang, “Rapid colorimetric assay for cell growth and survival, Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability”, J. Immunol. Methods, 89, 271–277, 1986.
N. Diaz, A. Nicolau, G. S. Carvalho, M. Mota y N. Lima, “Miniaturization and application of the MTT assay to evalue metabolic activity of protozoa in the presence of toxicants”, J. Basic Microbiol., 39(2), 103-108, 1999.
C. Y. Sasaki y A. Passniti, “Identification of anti-invasive but noncytotoxic chemotherapeutic agents using the tetrazolium dye MTT to quantitative viable cells in matrigel”, Bio-Techniques, 24, 1038-1043, 1998.
M. S. Quesada, “Determinación de la actividad antioxidante y el efecto citotóxico sobre líneas celulares tumorales de un extracto rico en polifenoles del fruto Bactris guineensis”, Tesis de Maestría. Ciudad Universitaria Rodrigo Facio, Costa Rica, 2020.
T. Gessner y U. Mayer, “Triarylmethane and Diarylmethane Dyes”, Ullman’s Encyclopedia of Industrial Chemistry, 6th ed, 2002.
D. A. Joelsson, “Practical Guide to Design of Experiments (DOE) for Assay Developers”, 2012.
R. I. Freshney, “Culture of Animal cells Freshney: A manual of Basic Techniqueand Specialized Applications”, 163 pp, 2010.
S. Coecke, M. Balls, G. Bowe, J. Davis, G.Gstraunthaler, T. Hartung, R. Hay, O. W. Merten, A. Price, L. Schechtman, G. Stacey y W. Stokes, “Guidance on Good Cell Culture Practice”, ATLA, 33, 261-287, 2006.
G. Stacey, “Cell lines used in the manufacture of biological products, in Encyclopedia of Cell Technology”, Spier, R., Ed., Wiley Interscience, New York, pp. 79–83, 2000.
N. Rieder, H. Gazzano-Santoro, M. Schenerman, R. Strause, C. Fuchs, A. Mire-Sluis y L. D. McLeod, “The Roles of Bioactivity Assays in Lot Release and Stability Testing”, BioProcess International, 8(6), 33-42, 2010.
G. Stacey, “Fundamental Issues for Cell-Line Banks in Biotechnology and Regulatory Affairs”, Cell Biology, NIBSC, South Mimms, UK, 2004.
R. J. Hay, “ATCC Quality controls methods for cell lines”. American Type Culture collection, Rockville MD, 1985.
G. N. Stacey y A. Doyle, “Cell banking, in Encyclopedia of Cell Technology”, Spier, R., Ed., Wiley Interscience, New York, pp. 293–320, 2000.
D. J. Finney, “Statistical Methods in Biological Assays”, Ed. Griffin, 1964.
A. Rosso, “Statistical analysis of experimental designs applied to biological assays”, Master thesis, School of Economics and management, 2010.
D. M. Rocke, “Design and analysis of experiments with high throughput biological assay data”, Seminars in Cell & Developmental Biology, 15, 703, 2004.
D. Lansky, “Strip-Plot Designs, Mixed Models, and Comparisons Between Linear and Nonlinear Models for Microtitre Plate Bioassays in the Design and Analysis of Potency Assays”, Dev. Biol, 107, 11–23, 2002.
C. P. Quesenberry, “The effect of sample size on estimated limits for and X control charts”, J. Quality Technology, 25(4), 237-247, 1993.